News & Views
Agreement Provides for Complete Biomanufacturing Provision
Jul 08 2016
Horizon Discovery Group plc has entered into a non-exclusive Licensing Agreement with ProteoNic B.V. to provide the CHOGUN expression vector to customers alongside Horizon’s HD-BIOP3 GS Null CHO cell line as standard, providing a complete biomanufacturing platform.
Paul Morrill, President, Products at Horizon Discovery Group commented: “Horizon’s GS Null CHO cell line, generated through the Company’s gene editing platform, has undergone extensive validation to confirm its suitability for biomanufacturing. By including ProteoNic’s powerful expression vector, we are now able to offer customers a complete platform that showcases the full capabilities of these cells.”
Victor Schut, Chief Business Officer, ProteoNic said: “The CHOGUN vector has proven to be extremely effective in a variety of cell lines including Horizon’s GS Null CHO cell line. We are excited to offer it to Horizon’s customers, providing another channel to access the 2G UNic technology for improved recombinant protein production. We believe that this platform is an attractive alternative for any other therapeutics, including biosimilars, producing system in the market today. We look forward to continuing to work together on future projects.”
Financial details of the agreement were not disclosed
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Microbiology Society Annual Conference 2024
Apr 08 2024 Edinburgh 2024
Apr 09 2024 Munich, Germany
Apr 10 2024 Helsinki, Finland
Analytica Anacon India & IndiaLabExpo
Apr 15 2024 Mumbai, India
Apr 16 2024 Moscow, Russia